XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Adjustment [Member]
Redeemable Convertible Preferred Stock [Member]
Redeemable Convertible Preferred Stock [Member]
Adjustment [Member]
Common Stock [Member]
Common Stock [Member]
Adjustment [Member]
Preferred Stock [Member]
Redeemable Convertible Preferred Stock [Member]
Preferred Stock [Member]
Redeemable Convertible Preferred Stock [Member]
Adjustment [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Adjustment [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Adjustment [Member]
Other Comprehensive Income [Member]
Other Comprehensive Income [Member]
Adjustment [Member]
Balance at Beginning at Dec. 31, 2020 $ (166,708) $ (166,708)       $ 8 $ 274,960 $ 274,960 $ 19,928 $ 19,920 $ (187,691) $ (187,691) $ 1,055 $ 1,055
Balance at Beginning (in Shares) at Dec. 31, 2020     31,330,513 283,843,764 8,654,869 78,410,162                
Net loss (15,882)                   (15,882)      
Exercise of stock options (in Shares)         545,527                  
Exercise of stock options 542               542          
Stock-based compensation 1,102               1,102          
Other comprehensive income (loss) 741                       741  
Balance Ending at Mar. 31, 2021 (180,205)       $ 8   274,960   21,564   (203,573)   1,796  
Balance Ending (in Shares) at Mar. 31, 2021     283,843,764   78,955,689                  
Balance at Beginning at Dec. 31, 2020 (166,708) (166,708)       $ 8 274,960 274,960 19,928 19,920 (187,691) (187,691) 1,055 1,055
Balance at Beginning (in Shares) at Dec. 31, 2020     31,330,513 283,843,764 8,654,869 78,410,162                
Net loss (120,516)                          
Stock-based compensation                 21,793          
Balance Ending at Sep. 30, 2021 674,126       $ 45       981,167   (308,207)   1,121  
Balance Ending (in Shares) at Sep. 30, 2021         449,039,446                  
Balance at Beginning at Dec. 31, 2020 (166,708) $ (166,708)       $ 8 274,960 $ 274,960 19,928 $ 19,920 (187,691) $ (187,691) 1,055 $ 1,055
Balance at Beginning (in Shares) at Dec. 31, 2020     31,330,513 283,843,764 8,654,869 78,410,162                
Retroactive application of Exchange Ratio         $ 8       (8)          
Retroactive application of Exchange Ratio (Shares)     252,513,251   69,755,293                  
Balance Ending at Dec. 31, 2021 698,448       $ 45       1,002,106   (305,011)   1,308  
Balance Ending (in Shares) at Dec. 31, 2021         450,180,479                  
Balance at Beginning at Mar. 31, 2021 (180,205)       $ 8   274,960   21,564   (203,573)   1,796  
Balance at Beginning (in Shares) at Mar. 31, 2021     283,843,764   78,955,689                  
Net loss (16,665)                   (16,665)      
Exercise of stock options (in Shares)         225,930                  
Exercise of stock options 230               230          
Stock-based compensation 1,278               1,278          
Other comprehensive income (loss) 333                       333  
Balance Ending at Jun. 30, 2021 (195,029)       $ 8   274,960   23,072   (220,238)   2,129  
Balance Ending (in Shares) at Jun. 30, 2021     283,843,764   79,181,619                  
Net loss (87,969)                   (87,969)      
Exercise of stock options (in Shares)         2,631,832                  
Exercise of stock options 1,999               1,999          
Stock-based compensation 21,793                          
Exercise of preferred stock warrants (in Shares)     817,981                      
Exercise of preferred stock warrants 6,514               6,514          
Common stock issued upon exercise of Public and Private Warrants (in Shares)         878,887                  
Exchange of preferred stock warrants for common stock warrants 2,975               2,975          
Conversion of redeemable convertible preferred stock to common stock (in Shares)     284,661,745   284,661,745                  
Conversion of redeemable convertible preferred stock to common stock 274,961       $ 29   $ (274,960)   274,932          
Reverse recapitalization, net of transaction costs 649,890       $ 8       649,882          
Reverse recapitalization, net of transaction costs (in Shares)         81,685,363                  
Common stock issued upon exercise of warrants (in Shares)         878,887                  
Other comprehensive income (loss) (1,008)                       (1,008)  
Balance Ending at Sep. 30, 2021 674,126       $ 45       981,167   (308,207)   1,121  
Balance Ending (in Shares) at Sep. 30, 2021         449,039,446                  
Balance at Beginning at Dec. 31, 2021 698,448       $ 45       1,002,106   (305,011)   1,308  
Balance at Beginning (in Shares) at Dec. 31, 2021         450,180,479                  
Net loss (26,709)                   (26,709)      
Issuance of common stock under equity plans, Shares         7,883,569                  
Issuance of common stock under equity plans 1,020       $ 1       1,019          
Stock-based compensation 14,116               14,116          
Common stock issued upon exercise of Public and Private Warrants 44,844               44,844          
Common stock issued upon exercise of Public and Private Warrants (in Shares)         4,554,830                  
Issuance of common stock for acquisition, Shares         123,934                  
Common stock issued upon exercise of warrants (in Shares)         4,554,830                  
Other comprehensive income (loss) 876                       876  
Balance Ending at Mar. 31, 2022 732,595       $ 46       1,062,085   (331,720)   2,184  
Balance Ending (in Shares) at Mar. 31, 2022         462,742,812                  
Balance at Beginning at Dec. 31, 2021 698,448       $ 45       1,002,106   (305,011)   1,308  
Balance at Beginning (in Shares) at Dec. 31, 2021         450,180,479                  
Net loss (98,736)                          
Balance Ending at Sep. 30, 2022 $ 690,836       $ 47       1,098,892   (403,747)   (4,356)  
Balance Ending (in Shares) at Sep. 30, 2022 447,919,591       472,746,850                  
Balance at Beginning at Mar. 31, 2022 $ 732,595       $ 46       1,062,085   (331,720)   2,184  
Balance at Beginning (in Shares) at Mar. 31, 2022         462,742,812                  
Net loss (37,417)                   (37,417)      
Issuance of common stock under equity plans, Shares         3,594,963                  
Issuance of common stock under equity plans 3,726       $ 1       3,725          
Stock-based compensation 15,580               15,580          
Issuance of common stock for acquisition, Shares         2,039,290                  
Other comprehensive income (loss) (1,030)                       (1,030)  
Balance Ending at Jun. 30, 2022 713,454       $ 47       1,081,390   (369,137)   1,154  
Balance Ending (in Shares) at Jun. 30, 2022         468,377,065                  
Net loss (34,610)                   (34,610)      
Issuance of common stock under equity plans, Shares         4,245,851                  
Issuance of common stock under equity plans 666               666          
Stock-based compensation 16,836               16,836          
Issuance of common stock for acquisition, Shares         123,934                  
Other comprehensive income (loss) (5,510)                       (5,510)  
Balance Ending at Sep. 30, 2022 $ 690,836       $ 47       $ 1,098,892   $ (403,747)   $ (4,356)  
Balance Ending (in Shares) at Sep. 30, 2022 447,919,591       472,746,850